MetaCap

IceCure Medical (ICCM) vs SeaStar Medical (ICU)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SeaStar Medical is the larger company by market cap ($5.0 million vs $4.5 million), about 1.1 times the size. IceCure Medical converts more of its revenue into profit, with a net margin of -445.6% versus -984.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ICCM-30.38%ICU-74.87%
+8%-38%-83%
Oct 7, 20261 yearNov 20, 2026
ICCM-27.22%ICU-74.10%
+4%-38%-81%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ICCM versus ICU key metrics
MetricICCMICU
Share price$0.8006$0.935
Market cap$4.45M$4.97M
1-day change-19.71%-10.95%
YTD return—-61.04%
1-year return—-69.34%
5-year return—-99.96%
EPS (TTM)$-6.84$-2.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.38M$1.23M
Revenue growth (YoY)+2.67%+814.07%
Net income (latest FY)$-15.06M$-12.15M
Gross margin36.28%95.71%
Operating margin-446.70%-986.63%
Net margin-445.61%-984.60%
52-week high$22.20$5.38
52-week low$0.65$0.761
Distance from 52-week high-96.39%-82.62%
Analyst consensusnonenone
Avg. price target upside+2731.63%+969.52%
Average volume186.02K196.27K
Shares outstanding5.56M5.32M
Employees6718
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • IceCure Medical is more profitable, keeping -445.6 cents of every revenue dollar as net income versus -984.6 cents for SeaStar Medical.
  • SeaStar Medical grew revenue faster in its latest fiscal year (+814.07% vs +2.67%).

About IceCure Medical

ICCM stock →

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.

Health Care · Medical/Dental Instruments · 67 employees

About SeaStar Medical

ICU stock →

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.

Health Care · Medical/Dental Instruments · 18 employees

ICCM vs ICU FAQ

Which is bigger, IceCure Medical or SeaStar Medical?

SeaStar Medical (ICU) is larger, with a market capitalization of $4.97M compared with $4.45M for IceCure Medical (ICCM).

Are IceCure Medical and SeaStar Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons